Search
for
Sort by
Research 631–660 of 1000+
- Radiofrequency treatment induces fibroblast growth factor 2 expression and subsequently promotes neocollagenesis and neoangiogenesis in the skin tissue
- Psychological aspects of hyperandrogenic states in late adolescent and young women
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Topically applied minoxidil may cause fetal malformation: A case report
- Trichotillomania: a good response to treatment with N-acetylcysteine
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Clinical and histological study of permanent alopecia after bone marrow transplantation
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Prevention of chemically induced hair damage by means of treatment based on proteins and polysaccharides
- Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment
- Characterization of minoxidil/hydroxypropyl-β-cyclodextrin inclusion complex in aqueous alginate gel useful for alopecia management: Efficacy evaluation in male rat
- Keratosis follicularis spinulosa decalvans in a female
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- Antiandrogen Drugs Lower Serum Prostate-Specific Antigen (PSA) Levels in Hirsute Subjects: Evidence That Serum PSA Is a Marker of Androgen Action in Women<sup>1</sup>
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- Development of a Doxazosin and Finasteride Transdermal System for Combination Therapy of Benign Prostatic Hyperplasia
- Beyond the Surface: Understanding Demodex and Its Link to Blepharitis and Facial Dermatoses
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Follicular Transplantation for the Correction of Various Stigmas After Rhytidoplasty
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Do you know how to recommend a wig to your patient?
- Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium
- “MATH+” Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale